Ipamorelin research has also explored nitrogen metabolism, with some findings suggesting a role in reducing nitrogen loss in experimental conditions
Together, they balance each other's effects, with HGH increasing IGF-1 binding proteins to enhance IGF-1 bioavailability and tissue effects
4,5 These included significant decreases in respiratory distress, BCD, NEC, IVH and ROP, despite similar GA and birth anthropometrics
Randomized, double-blind, placebo-controlled, and replicated is strong
BS: Writing review & editing
Tesamorelin is an FDA-approved prescription drug (brand name Egrifta), cleared in 2010 on the strength of multiple Phase 3 double-blind, placebo-controlled randomized trials for a specific, narrow indication: reducing excess abdominal fat in people with HIV-associated lipodystrophy